Table 5 Factors influencing the differences between the two evaluations of target organ damage in diabetics and patients with metabolic syndrome, in the multiple regression analysis

D-IMT Adjusted R2 = 0.001

D-IMT Adjusted R2 = 0.038

Constant

-0.01

-0.09 to 0.09

0.97

constant

0.04

0.06 to 0.14

0.40

Age

-0.01

-0.01 to 0.01

0.43

Age

-0.01

0.01 to 0.01

0.14

Gender

0.02

-0.01 to 0.05

0.21

Gender

0.02

0.02 to 0.06

0.32

D-PWV Adjusted R ² = 0.133

D-PWV Adjusted R ² = 0.235

Constant

-1.97

-6.87 to 2.93

0.42

constant

2.57

1.34 to 6.48

0.19

Age

0.04

-0.04 to 0.12

0.28

Age

-0.05

0.12 to 0.01

0.09

Gender

0.22

-1.07 to 1.51

0.73

Gender

1.13

0.59 to 2.86

0.19

D-DBP

0.05

0.01 to 0.08

0.01

D-FHTA

-1.44

2.39 to -0.50

0.01

D-PDV DE CORNELL Adjusted R ² = 0.104

D-PDV DE CORNELL Adjusted R ² = 0.258

Constant

124.16

-889.48 to 1137.79

0.80

constant

-74.32

-600.14 to 451.49

0.77

Age

-2.57

-18.74 to 13.59

0.75

Age

4.63

4.15 to 13.421

0.29

Gender

-18.44

-248.79 to 285.66

0.89

Gender

-19.19

251.72 to 213.33

0.87

D-DBP

7.89

0.88 to 14.90

0.03

D-FHTA

-440.80

139.92 to 741.69

0.01

D-ABI Adjusted R ² = 0.036

D-ABI Adjusted R ² = 0.005

Constant

-0.095

-0.25 to 0.06

0.22

constant

-0.06

0.25 to 0.12

0.51

Age

0.02

0.01 to 0.04

0.12

Age

0.01

0.01 to 0.01

0.36

Gender

0.04

-0.01 to 0.10

0.14

Gender

0.01

0.03 to 0.03

0.23